Alnylam Pharmaceuticals (ALNY) Stock: Gaining On Planned Phase III Trial

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is having a pretty strong start to the trading session today, and for good reason. The company announced that it has reached an agreement with the FDA surrounding a planned Phase III clinical trial. As a result, investors got excited and the stock is finding its way upward. As is … Read more

In The Market Today: Ariad Pharmacueticals (ARIA) | Baxalta (BXLT) | MannKind (MNKD) | The Medicines Company (MDCO) | Twitter (TWTR)

Ariad Pharmaceuticals: Is An Acquisition Coming? Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) | Baxalta Inc (NYSE: BXLT) On Friday, Bloomberg broke a story stating that Ariad Pharmaceuticals and Baxalta were in the midst of acquisition talks. The idea here is that Baxalta wants to purchase Ariad Pharmaceuticals to get hold of the work they’ve been doing … Read more

The Medicines Company (MDCO) Climbs On Positive Data

The Medicines Company (NASDAQ: MDCO) The Medicines company is having an incredible day in the market today after announcing data from its recent study looking into ALN-PCSsc, a new cholesterol drug. Today, we’ll talk about the data that was released, how it has affected the market so far today, and what we can expect to … Read more